BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26514959)

  • 1. Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial.
    Hendriks AA; Khan M; Geller L; Kardos A; de Vries LJ; Yap SC; Wijchers SA; Theuns DA; Szili-Torok T
    Trials; 2015 Oct; 16():487. PubMed ID: 26514959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
    Dukkipati SR; d'Avila A; Soejima K; Bala R; Inada K; Singh S; Stevenson WG; Marchlinski FE; Reddy VY
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):185-94. PubMed ID: 21270104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy.
    Di Biase L; Santangeli P; Burkhardt DJ; Bai R; Mohanty P; Carbucicchio C; Dello Russo A; Casella M; Mohanty S; Pump A; Hongo R; Beheiry S; Pelargonio G; Santarelli P; Zucchetti M; Horton R; Sanchez JE; Elayi CS; Lakkireddy D; Tondo C; Natale A
    J Am Coll Cardiol; 2012 Jul; 60(2):132-41. PubMed ID: 22766340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Cesario DA; Vaseghi M; Boyle NG; Fishbein MC; Valderrábano M; Narasimhan C; Wiener I; Shivkumar K
    Heart Rhythm; 2006 Jan; 3(1):1-10. PubMed ID: 16399044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?
    Schmidt B; Chun KR; Baensch D; Antz M; Koektuerk B; Tilz RR; Metzner A; Ouyang F; Kuck KH
    Heart Rhythm; 2010 Dec; 7(12):1746-52. PubMed ID: 20709191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique.
    Berruezo A; Fernández-Armenta J; Mont L; Zeljko H; Andreu D; Herczku C; Boussy T; Tolosana JM; Arbelo E; Brugada J
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):111-21. PubMed ID: 22205683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
    Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
    Pokushalov E; Romanov A; Turov A; Artyomenko S; Shirokova N; Karaskov A
    Heart Rhythm; 2010 Oct; 7(10):1406-10. PubMed ID: 20601157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.
    Berruezo A; Acosta J; Fernández-Armenta J; Pedrote A; Barrera A; Arana-Rueda E; Bodegas AI; Anguera I; Tercedor L; Penela D; Andreu D; Perea RJ; Prat-González S; Mont L
    Europace; 2017 Apr; 19(4):607-616. PubMed ID: 28431051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Mathuria N; Tung R; Shivkumar K
    Curr Cardiol Rep; 2012 Oct; 14(5):577-83. PubMed ID: 22843484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction.
    Arenal Á; Hernández J; Calvo D; Ceballos C; Atéa L; Datino T; Atienza F; González-Torrecilla E; Eídelman G; Miracle Á; Avila P; Bermejo J; Fernández-Avilés F
    Am J Cardiol; 2013 Feb; 111(4):499-505. PubMed ID: 23228925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
    Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia.
    Aryana A; d'Avila A; Heist EK; Mela T; Singh JP; Ruskin JN; Reddy VY
    Circulation; 2007 Mar; 115(10):1191-200. PubMed ID: 17296855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial mapping of sustained ventricular tachycardia in nonischemic heart disease.
    Silva GG; Veloso HH; Leite LR; Farias RL; Paola AA
    Arq Bras Cardiol; 2011 Feb; 96(2):114-20. PubMed ID: 21271170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of subepicardial ventricular tachycardia using electroanatomic mapping.
    Ouyang F; Bänsch D; Schaumann A; Ernst S; Linder C; Falk P; Hachiya H; Kuck KH; Antz M
    Herz; 2003 Nov; 28(7):591-7. PubMed ID: 14689119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy.
    Piers SR; Tao Q; van Huls van Taxis CF; Schalij MJ; van der Geest RJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):875-83. PubMed ID: 24036134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.